/ /

Levine_Norman-2.jpg
Norman Levine, M.D.
Norman Levine, M.D., is a private practitioner in Tucson, Ariz. He also is a member of the Dermatology Times Editorial Advisory board and a co-medical editor.
Crazy patient stories and how I deal with them
Norman Levine, M.D., believes that acquiring a patient's full history isn't always as helpful as physicians make them out to be, and in fact, can occasionally be harmful.
If I ruled the (dermatology) world
Dr. Norman Levine muses on an alternate universe in which he makes the rules for anything related to the dermatology specialty. After reading, he notes many may be relieved that he will never rule the (dermatology) world. But are changes necessary? You tell us.
Contrary to public belief
A seasoned dermatologist shares his views about dermatologists being overpaid, when to treat and when not to treat, and how best to stay informed.
Can we cut back on lab testing?
We utilize numerous medications in dermatology where potentially severe side effects can occur and can be detected by laboratory analysis. However, many commonly prescribed drugs rarely cause problems but have acquired the reputation of potentially toxic agents, which require close laboratory monitoring. Although many would disagree me, these are the medications that dermatologists over test.
Dermatologists are wound care specialists
When routine skin injuries such as mild burns, skin tears, uncomplicated stasis ulcers and minor post-operative wound complications become a routine part of the wound care center purview and are no longer considered a part of what dermatologists can do or wish to do, the dermatology discipline shrinks further toward a marginalized specialty. Learn more
The tale of the $220 tube of clobetasol cream
The economic realities of increased prices for medications strikes at the heart of the services that dermatologists provide for patients.
Sunscreen safety and efficacy
Sunscreen safety and efficacy
Sunscreens have become a staple tool in our fight against skin cancer. In spite of the great progress made in educating the public about the value of sunscreens, there remain many doubters about the safety and efficacy of these chemicals. Darrell Rigel, M.D., clinical professor of dermatology at New York University, will help to set the record straight on these agents.
PODCAST: Expert insights in managing vitiligo, part 2 on dyspigmentation
Two of the most vexing skin conditions that dermatologists manage are melasma and vitiligo. In one condition, too much pigmentation is present because of genetic, hormonal and environmental factors. In the other, there is a lack of melanin in the skin, presumably on an autoimmune basis. In part two of this discussion on dyspigmentation conditions, Seemal Desai, M.D., who is a board-certified dermatologist, clinical assistant professor in the department of dermatology at University of Texas, Southwestern Medical Center in Dallas, and medical director of Innovative Dermatology, discusses treatment options for vitiligo with Dermatology Times editorial advisor, Dr. Norman Levine.
Should dermatologists offer EBT?
Electronic surface brachytherapy is a low-energy radiation treatment for skin cancer. Radiologists are required to administer the treatment, which is controversial in terms of reimbursement and collaborative requirements.
PODCAST: Expert insights in managing melasma, part 1 on dyspigmentation
Two of the most vexing skin conditions that dermatologists manage are melasma and vitiligo. In one condition, too much pigmentation is present because of genetic, hormonal and environmental factors. In the other, there is a lack of melanin in the skin, presumably on an autoimmune basis. In part one of this discussion on dyspigmentation conditions, Seemal Desai, M.D., who is a board-certified dermatologist, clinical assistant professor in the department of dermatology at University of Texas, Southwestern Medical Center in Dallas, and medical director of Innovative Dermatology, discusses treatment options for melasma Dermatology Times editorial advisor, Dr. Norman Levine.

Poll

View Results